Skip NavigationSkip to Content

Analysis of the interaction between the HIV-Inactivating protein cyanovirin-N and soluble forms of the envelope glycoproteins gp120 and gp41

  1. Author:
    O'Keefe, B. R.
    Shenoy, S. R.
    Xie, D.
    Zhang, W. T.
    Muschik, J. M.
    Currens, M. J.
    Chaiken, I.
    Boyd, M. R.
  2. Author Address

    Frederick Canc Res & Dev Ctr, Div Canc Treatment & Diag, Dev Therapeut Program, Lab Drug Discovery Res & Dev, SAIC Frederick, Bldg 1052, Rm 121, Frederick, MD 21702 USA. Frederick Canc Res & Dev Ctr, Div Canc Treatment & Diag, Dev Therapeut Program, Lab Drug Discovery Res & Dev, SAIC Frederick, Frederick, MD 21702 USA. Frederick Canc Res & Dev Ctr, SAIC Frederick, Struct Biochem Program, Frederick, MD 21702 USA. Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA.
    1. Year: 2000
  1. Journal: Molecular Pharmacology
    1. 58
    2. 5
    3. Pages: 982-992
  2. Type of Article: Article
  1. Abstract:

    The novel virucidal protein cyanovirin-N (CV-N) binds with equally high affinity to soluble forms of either H9 cell- produced or recombinant glycosylated HIV-1 gp120 (sgp120) or gp160 (sgp160). Fluorescence polarization studies showed that CV-N is also capable of binding to the glycosylated ectodomain of the HIV-envelope protein gp41 (sgp41) (as well as SIV glycoprotein 32), albeit with considerably lower affinity than the sgp120/CV-N interaction. Pretreatment of CV-N with either sgp120 or sgp41 abrogated the neutralizing activity of CV-N against intact, infectious HIV-1 virions. Isothermal calorimetry and optical biosensor binding studies showed that CV-N bound to recombinant sgp120 with a K-d value ranging from 2 to 45 nM and to sgp41 with a K-d value of 606 nM; furthermore, they indicated an approximate 5:1 stoichiometry for CV-N binding to sgp120 and a 1:1 stoichiometry for CV-N binding to sgp41. Circular dichroism studies additionally illuminated the binding of CV-N with both sgp120 and sgp41, providing the first direct evidence that conformational changes are a consequence of CV-N interactions with both HIV-1 envelope glycoproteins.

    See More

External Sources

  1. No sources found.

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel